Status:
TERMINATED
Comparison of Iodine-124 (I-124) and Iodine-131 (I-131) Radiopharmacokinetics in Patients Prepared With Recombinant Human TSH Injection (rhTSH)
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is to compare the radiopharmacokinetics of I-124 to the radiopharmacokinetics of I-131 in patients who have well-differentiated thyroid cancer after recombinant human thyroid-stimu...
Detailed Description
Radiopharmacokinetics and Dosimetric Calculations A tracer dosage of either I-131 or I-124 is first administered to the patient, and the clearance is then followed for the specified period. In the cl...
Eligibility Criteria
Inclusion
- 18 years or older
- Well-differentiated thyroid carcinoma
- Referred for I-131 dosimetry
- Preparation with Recombinant Human TSH (rh TSH)
Exclusion
- \< 18 years of age
- Pregnancy or breast feeding
- Inability to comply with instructions
- Simultaneous participation or participation in any other research study within the last month
- A body weight greater than 350 lbs
- A creatinine \> 1.5 mg/ml for males and 1.4 mg/ml for females
- Preparation with thyroid hormone withdrawal(THW)
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00926978
Start Date
December 1 2008
End Date
October 1 2018
Last Update
November 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010